<DOC>
	<DOC>NCT02593383</DOC>
	<brief_summary>evaluate the safety and efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in treatment of chinese patients with acne.</brief_summary>
	<brief_title>Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne</brief_title>
	<detailed_description />
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<criteria>1. Age from 18 to 40 years old, female or male; 2. Class IIII of Acne vulgaris according to the International Modified PILLSBURY Classification; 3. Patients voluntarily take part in the study and sign the ICF. 1. The subject is known to be allergic to adapalene, clindamycin hydrochloride, clindamycin, and / or any components of gel excipient; 2. Patients with secondary acne including occupational acne and corticosteroidinduced acne; 3. The affected skin has other concomitant lesion (such as solar dermatitis, psoriasis, seborrheic dermatitis, eczema and extremely severe acne) which may impact the efficacy evaluation; 4. Subject has the history of regional enteritis, ulcerative colitis or antibioticassociated colitis; 5. Patient has history of severe cardiac disease and hypertension; 6. Patient has severe liver and kidney diseases with AST/ALT more than twice upper limitation, or Cr, total cholesterol and triglycerides above normal range; 7. Patients with severe endocrine diseases, blood diseases, and neuropsychiatric disorders; 8. Patients are known to have severe immune dysfunction, or need longterm use of corticosteroids or immunosuppressive agents; 9. Pregnant or breastfeeding women, or unwilling to take effective contraceptive measures during the study; 10. Alcoholic patients or drug abusers; 11. Patient has used other acne drugs topically within 2 weeks before the study start; 12. Patient has been administered with victoria A acid, vitamins, and antibiotics within 4 weeks before the study start; 13. Patient has participated in other study within 3 months before the study start; 14. The subject is not fit to take part in this study in the judgment of the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
</DOC>